The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples